Psagot Value Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,420
| Closed | -$371K | – | 344 |
|
|
2022
Q2 | $371K | Buy |
2,420
+502
| +26% | +$76.7K | 0.09% | 137 |
|
|
2022
Q1 | $311K | Sell |
1,918
-2,442
| -56% | -$355K | 0.07% | 159 |
|
|
2021
Q4 | $590K | Buy |
4,360
+3,300
| +311% | +$390K | 0.11% | 134 |
|
|
2021
Q3 | $114K | Sell |
1,060
-388
| -27% | -$44.3K | 0.02% | 296 |
|
|
2021
Q2 | $163K | Hold |
1,448
| – | – | 0.01% | 309 |
|
|
2021
Q1 | $157K | Buy |
1,448
+388
| +37% | +$41.5K | ﹤0.01% | 284 |
|
|
2020
Q4 | $114K | Buy |
1,060
+1,000
| +1,667% | +$96.1K | ﹤0.01% | 274 |
|
|
2020
Q3 | $5K | Sell |
60
-1,205
| -95% | -$113K | ﹤0.01% | 380 |
|
|
2020
Q2 | $124K | Buy |
1,265
+60
| +5% | +$5.28K | ﹤0.01% | 266 |
|
|
2020
Q1 | $92K | Sell |
1,205
-4,350
| -78% | -$371K | ﹤0.01% | 269 |
|
|
2019
Q4 | $492K | Hold |
5,555
| – | – | 0.02% | 219 |
|
|
2019
Q3 | $421K | Sell |
5,555
-150
| -3% | -$10.3K | 0.02% | 200 |
|
|
2019
Q2 | $415K | Hold |
5,705
| – | – | 0.02% | 218 |
|
|
2019
Q1 | $460K | Sell |
5,705
-2,795
| -33% | -$229K | 0.02% | 220 |
|
|
2018
Q4 | $784K | Sell |
8,500
-9,440
| -53% | -$830K | 0.04% | 186 |
|
|
2018
Q3 | $1.7M | Sell |
17,940
-710
| -4% | -$67.3K | 0.08% | 118 |
|
|
2018
Q2 | $1.73M | Hold |
18,650
| – | – | 0.08% | 111 |
|
|
2018
Q1 | $1.76M | Sell |
18,650
-6,550
| -26% | -$720K | 0.08% | 125 |
|
|
2017
Q4 | $2.44M | Buy |
25,200
+7,500
| +42% | +$707K | 0.11% | 107 |
|
|
2017
Q3 | $1.57M | Buy |
17,700
+2,100
| +13% | +$160K | 0.07% | 136 |
|
|
2017
Q2 | $1.13M | Buy |
15,600
+3,200
| +26% | +$215K | 0.05% | 136 |
|
|
2017
Q1 | $808K | Sell |
12,400
-1,000
| -7% | -$62.9K | 0.03% | 155 |
|
|
2016
Q4 | $839K | Buy |
13,400
+6,900
| +106% | +$421K | 0.04% | 152 |
|
|
2016
Q3 | $410K | Buy |
+6,500
| New | +$421K | 0.02% | 185 |
|
|
2016
Q1 | – | Sell |
-17,650
| Closed | -$1.05M | – | 370 |
|
|
2015
Q4 | $1.05M | Sell |
17,650
-96,806
| -85% | -$5.58M | 0.04% | 161 |
|
|
2015
Q3 | $6.23M | Sell |
114,456
-114,443
| -50% | -$7.45M | 0.23% | 79 |
|
|
2015
Q2 | $15.4M | Sell |
228,899
-6
| -0% | -$392 | 0.49% | 50 |
|
|
2015
Q1 | $13.4M | Buy |
228,905
+194,834
| +572% | +$11.8M | 0.42% | 51 |
|
|
2014
Q4 | $2.23M | Sell |
34,071
-238,219
| -87% | -$15M | 0.08% | 109 |
|
|
2014
Q3 | $15.7M | Buy |
+272,290
| New | +$15.1M | 0.53% | 48 |
|
Other funds holding ABBV
Psagot Value Holdings's ABBV Position: Q3 2022 in Review
Psagot Value Holdings sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 2,420 shares — an estimated $371K sold.
Psagot Value Holdings first reported a position in ABBV in Q3 2014 and held it in 30 quarters. The position peaked at $15.7M in Q3 2014. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Psagot Value Holdings reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
- Psagot Value Holdings sold 2,420 AbbVie shares in Q3 2022, an estimated $371K.
- Psagot Value Holdings first reported a position in AbbVie in Q3 2014 and held it in 30 quarters.
- Psagot Value Holdings's AbbVie position peaked at $15.7M in Q3 2014.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Psagot Value Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.